Utility of routine cardiac ejection fraction (EF) measurement prior to anthracycline-based chemotherapy (ABC) in patients with diffuse large b-cell lymphoma (DLBCL).

6101 Background: Routine EF measurement in DLBCL patients prior to ABC is recommended by the National Comprehensive Cancer Network and an eligibility criterion for most DLBCL trials sponsored by US...